Otarmeni
2 stories
-
healthFDA Approves Groundbreaking Gene Therapy for Genetic Hearing Loss
The FDA has approved Otarmeni, the first gene therapy to treat severe to profound hearing loss linked to the OTOF gene, offering new hope for patients.
-
healthFDA Approves First Gene Therapy for Inherited Deafness
Regeneron's Otarmeni receives FDA approval, marking a significant advancement in treating OTOF gene-related hearing loss in children and adults.